Skip to content

People
Capabilities
Main /
Capabilities
Capabilities

Antitrust

Artificial Intelligence

Business Restructuring

Corporate & Transactional

Crisis Management

Data, Privacy & Cybersecurity

Employee Benefits & Executive Compensation

Employment

Government & Lobbying Strategies

Government Contracts

Intellectual Property

International Trade

Investment Management

Litigation & Dispute Resolution

Mergers & Acquisitions

Private Client

Real Estate

Shareholder Activism

Strategic Solutions

Sustainability, Impact & ESG

Tax

Trade Secrets

White-Collar Defense & Government Investigations

Regional Markets

View all capabilities
Industries spotlight

Health & Life Sciences

Guiding health and life sciences transformation

Private Equity

Driving investment performance

Media, Entertainment & Sports

Turning creative assets into strategic value

View all
Industries
Main /
Industries
Industries

Accounting & Consulting Services

Alcohol

Digital Infrastructure

Energy & Infrastructure

Financial Services

FinTech & Blockchain

Food, Beverage & Agribusiness

Health & Life Sciences

Insurance

Media, Entertainment & Sports

Private Equity

Technology

Venture Capital & Emerging Growth

View all industries
Case studies

Zocdoc

How Zocdoc broke regulatory ground as an online healthcare resource

Doral Renewables

Doral Renewables’ drive to build sustainable solar solutions

Sustainable Procurement Pledge

Connecting the dots for supply chain sustainability

View all case studies
Insights
main /
Insights
Featured

main / Insights / Featured

Health & Life Sciences

Where MedTech is attracting PE attention with less FDA burden

White-Collar Defense

DOJ revises Justice Manual guidance on two key False Claims Act issues

Energy & Infrastructure

What the Copia Power sale signals for digital infrastructure investment

Topics

main / Insights / Topics

Private Capital

Global Privacy & Cybersecurity

Artificial Intelligence Law

US Policy Watch

View all insights
Categories

main / Insights / Categories

Articles

Client Alerts

Case Studies

Podcasts

Reports

Resources

Topics

Videos

Trending

main / Insights / Trending

Client alert DEA appears close to finalizing telemedicine special registration

Client alert 24-hour reporting deadline under the EU Cyber Resilience Act now in effect
- Articles
- Client Alerts
- Case Studies
- Podcasts
- Reports
- Resources
- Topics
- Videos
Events
Main /
Events
Upcoming events

Oct 19 – Oct 23

In-person Pepperdine’s Global Family Office Summit 2026

October 27, 2026

In-person San Francisco Private Funds Roundtable & Cocktail Reception

Oct 29

Virtual 340B: Back to Basics

Oct 22

Virtual Canary Forum 2026

Oct 27

Virtual Cybersecurity Risks in the Workforce: Emerging Threats and Employer Response

Nov 3

Virtual Managing Legal Risk in AI-Driven Employment Decisions

View all events
Featured

In-person

Life Sciences Investment Forum 2026

In-person

HPE Miami 2027
Careers

- English
- Deutsch
- Français
- Italiano

See all results for >

Newsroom Categories: Coverage

Could Providers Be Liable in Change Outage? Here’s What to Know

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Could Providers Be Liable in Change Outage? Here’s What to Know

May 13, 2024

Read time: 2 min

About Us

Related people

Ryan S. Higgins

Partner

Chicago

You may also like

Virtual

Enforcement Outlook | Key takeaways: Healthcare Litigation, Compliance, and Investigation Trends 

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Related

Health & Life Sciences United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

May 16, 2024
What to Know About Biden’s ACA Nondiscrimination Rule

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

What to Know About Biden’s ACA Nondiscrimination Rule

May 10, 2024

Read time: 2 min

About Us

Related people

Sarah G. Raaii

Partner

Chicago

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Employee Benefits & Executive Compensation United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

May 16, 2024
Comparison of third-party discovery in domestic and international arbitration

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Comparison of third-party discovery in domestic and international arbitration

May 15, 2024

Read time: 2 min

About Us

Related people

Jessica Sabbath

Counsel

Atlanta

Lisa M. Richman

Partner

Washington, DC

You may also like

Virtual

Enforcement Outlook | Key takeaways: Healthcare Litigation, Compliance, and Investigation Trends 

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Related

Litigation & Dispute Resolution United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

May 15, 2024
Dual-Track IPO-M&A Exit Strategies for Life Science Cos.

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Dual-Track IPO-M&A Exit Strategies for Life Science Cos.

May 9, 2024

Read time: 2 min

About Us

Related people

Kristian A. Werling

Partner

Chicago

Todd R. Kornfeld

Partner

New York – One Vanderbilt Avenue

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Corporate & Transactional United Kingdom United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

May 10, 2024
Federal Circuit Report

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Federal Circuit Report

May 8, 2024

Read time: 2 min

About Us

Related people

Benjamin N. Ediger, PhD

Associate

Austin

Amol Parikh

Partner

Chicago

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Intellectual Property United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

May 10, 2024
IRA Draft Guidance Leaves 340B Details Unclear

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

IRA Draft Guidance Leaves 340B Details Unclear

May 9, 2024

Read time: 2 min

About Us

Related people

Emily Jane Cook

Partner

Los Angeles, Washington, DC

You may also like

Virtual

Enforcement Outlook | Key takeaways: Healthcare Litigation, Compliance, and Investigation Trends 

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Related

Health & Life Sciences United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

May 10, 2024
Healthcare Services Report

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Healthcare Services Report

May 7, 2024

Read time: 2 min

About Us

Related people

Monica Wallace

Partner

Chicago

Sarah Kitchell

Partner

Boston

You may also like

Virtual

Enforcement Outlook | Key takeaways: Healthcare Litigation, Compliance, and Investigation Trends 

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Related

Health & Life Sciences United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

May 10, 2024
5 Climate Change Regulatory Issues Insurers Should Follow

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

5 Climate Change Regulatory Issues Insurers Should Follow

May 8, 2024

Read time: 2 min

About Us

Related people

Thomas M. Dawson

Partner

New York – One Vanderbilt Avenue

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Corporate & Transactional United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

May 10, 2024
New Value Based Payment Mechanisms, Ancillary Revenue Streams, and Stark Law W/ Nicholas F. Alarif

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

New Value Based Payment Mechanisms, Ancillary Revenue Streams, and Stark Law W/ Nicholas F. Alarif

May 8, 2024

Read time: 2 min

About Us

Related people

Nicholas F. Alarif

Partner

Washington, DC

You may also like

Virtual

Enforcement Outlook | Key takeaways: Healthcare Litigation, Compliance, and Investigation Trends 

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Related

Health & Life Sciences United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

May 10, 2024
Navigating the Pharma and Medtech Industries: Key Investment and Operational Drivers

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Navigating the Pharma and Medtech Industries: Key Investment and Operational Drivers

May 8, 2024

Read time: 2 min

Following their successful panel at McDermott’s HPE Miami 2024, the Firm health partners Sharon Lamb and Stephen W. Bernstein and associate Ashley Ogedegbe analyse key investment drivers in the pharma and medtech industries.

About Us

Related people

Sharon Lamb

Partner

London – 22 Bishopsgate

Stephen W. Bernstein

Partner

Boston

You may also like

Virtual

Enforcement Outlook | Key takeaways: Healthcare Litigation, Compliance, and Investigation Trends 

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Related

Health & Life Sciences United Kingdom United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

May 9, 2024

←Previous Page

1 … 115 116 117 118 119 … 349

Firm

About
Offices
Newsroom
Alumni
Careers

Sign In

McDermott Access

Related Sites

Farragut Square Group

Connect

Contact
Subscribe

ALWAYS BETTER

Legal Notices/Imprint
Privacy Policy
Terms of Use
Sitemap

Attorney advertising © 2026 McDermott Will & Schulte

Disclaimer

Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott Will & Schulte via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott Will & Schulte from representing any other person or firm in any matter; and will not obligate McDermott Will & Schulte to keep confidential the information you provide. McDermott Will & Schulte cannot enter into an attorney-client relationship with you until McDermott Will & Schulte has determined that doing so will not create a conflict of interest and until you and McDermott Will & Schulte have entered into a written agreement or engagement letter that sets forth the terms of our relationship.